Assessment of conservative dietary management as a method for normalization of 24-h urine pH in stone formers.


Journal

Urolithiasis
ISSN: 2194-7236
Titre abrégé: Urolithiasis
Pays: Germany
ID NLM: 101602699

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 17 01 2019
accepted: 29 04 2019
pubmed: 8 5 2019
medline: 7 1 2021
entrez: 8 5 2019
Statut: ppublish

Résumé

Low urine pH is a metabolic risk factor for stone formation. While medical therapy is typically prescribed (as urinary alkalinization), patients typically prefer dietary modifications. We aimed to assess capacity to alter urine pH with dietary management alone. We analyzed a retrospective cohort of stone formers seen between 2000 and 2015 with multiple 24-h urine collections (24hUC). Patients ≥ 18 years old with low urine pH (< 6.0) were included; those prescribed alkalinizing agents or thiazides were excluded. Demographic data, 24hUC parameters, and medications were abstracted. 24hUC was utilized to calculate gastrointestinal alkali absorption (GIAA). The primary outcome was urine pH ≥ 6.0 on second 24hUC. Predictors were selected utilizing multivariable logistic regression. The database consisted of 2197 stone formers; 224 of these met inclusion criteria. On second 24hUC, 124 (55.4%) achieved a favorable pH ≥ 6.0. On univariable analysis, a second pH ≥ 6.0 was associated with high initial pH, low initial sulfate, younger age, increase in citrate/GIAA/urine volume, and decrease in ammonium (P < 0.02). On multivariable analysis, high initial pH (OR = 23.64, P < 0.001), high initial GIAA (OR = 1.03, P = 0.001), lower initial sulfate (OR = 0.95, P < 0.001), increase in urine volume (OR = 2.19, P = 0.001), increase in GIAA (OR = 8.6, P < 0.001), increase in citrate (OR = 2.7, P = 0.014), decrease in ammonium (OR = 0.18, P < 0.001), and younger age (OR = 0.97, P = 0.025) were associated with a second pH ≥ 6.0. The analysis demonstrated a corrected AUC of 0.853. These data suggest that certain dietary recommendations (increases in urine volume, citrate, GIAA, and decreased acid load) may normalize urine pH in a select group of patients. This may allow urologists to counsel patients with low urine pH on possibility of success with dietary modification alone.

Identifiants

pubmed: 31062069
doi: 10.1007/s00240-019-01139-9
pii: 10.1007/s00240-019-01139-9
doi:

Substances chimiques

Alkalies 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-136

Références

J Am Soc Nephrol. 2009 Oct;20(10):2253-9
pubmed: 19679672
Urolithiasis. 2016 Feb;44(1):51-6
pubmed: 26614113
J Urol. 2014 Aug;192(2):316-24
pubmed: 24857648
J Bone Miner Res. 1993 Jul;8(7):789-94
pubmed: 8352061
J Urol. 2014 Feb;191(2):376-80
pubmed: 24018242
Eur Urol. 2012 Jul;62(1):160-5
pubmed: 22498635
J Urol. 2003 Feb;169(2):465-9
pubmed: 12544288
Ann Intern Med. 1997 Apr 1;126(7):497-504
pubmed: 9092314
J Endourol. 2014 Sep;28(9):1127-31
pubmed: 24846196
J Urol. 2009 Mar;181(3):1145-50
pubmed: 19152932
Int J Surg. 2016 Dec;36(Pt D):633-637
pubmed: 27840312
N Engl J Med. 1993 Mar 25;328(12):833-8
pubmed: 8441427
Adv Chronic Kidney Dis. 2013 Mar;20(2):165-74
pubmed: 23439376
Urology. 2015 Mar;85(3):568-73
pubmed: 25733267
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1834-1844
pubmed: 27445166
J Urol. 1996 Mar;155(3):839-43
pubmed: 8583588
J Urol. 2007 Apr;177(4):1358-62; discussion 1362; quiz 1591
pubmed: 17382731
Am J Physiol Renal Physiol. 2018 Apr 1;314(4):F623-F629
pubmed: 29357436
Am J Clin Nutr. 2010 Mar;91(3):565-70
pubmed: 20042524
J Endourol. 1999 Nov;13(9):679-85
pubmed: 10608521
Physiol Rep. 2017 Oct;5(19):
pubmed: 29038354
J Endourol. 2016 Apr;30(4):460-4
pubmed: 26738410
J Urol. 2001 Dec;166(6):2057-60
pubmed: 11696706
J Urol. 2009 Sep;182(3):998-1004
pubmed: 19616801
Kidney Int. 1989 Nov;36(5):915-7
pubmed: 2615198
Kidney Int. 2011 Feb;79(4):385-92
pubmed: 20927039

Auteurs

Daniel A Wollin (DA)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA. daniel.wollin@gmail.com.
Division of Urologic Surgery, Boston VA Healthcare System, West Roxbury, MA, USA. daniel.wollin@gmail.com.
Duke University Medical Center, Room 1573 White Zone, Box 3167, Durham, NC, 27710, USA. daniel.wollin@gmail.com.

Leah G Davis (LG)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.
Duke Cancer Center Biostatistics, Duke University Medical Center, Durham, NC, USA.

Brenton B Winship (BB)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.

Evan C Carlos (EC)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.

Westin R Tom (WR)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.

John R Asplin (JR)

Litholink Corporation, Laboratory Corporation of America Holdings®, Chicago, IL, USA.

Andrzej S Kosinski (AS)

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.

Charles D Scales (CD)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.

Michael N Ferrandino (MN)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.

Glenn M Preminger (GM)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.

Michael E Lipkin (ME)

Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH